347 related articles for article (PubMed ID: 3035246)
1. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir treatment of cytomegalovirus disease in immunocompromised children.
Gudnason T; Belani KK; Balfour HH
Pediatr Infect Dis J; 1989 Jul; 8(7):436-40. PubMed ID: 2547191
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
[TBL] [Abstract][Full Text] [Related]
5. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
Snydman DR
Rev Infect Dis; 1988; 10 Suppl 3():S554-62. PubMed ID: 2847293
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
[TBL] [Abstract][Full Text] [Related]
9. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.
Shepp DH; Dandliker PS; de Miranda P; Burnette TC; Cederberg DM; Kirk LE; Meyers JD
Ann Intern Med; 1985 Sep; 103(3):368-73. PubMed ID: 2992333
[TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.
Turgeon N; Fishman JA; Doran M; Basgoz N; Tolkoff-Rubin NE; Cosimi AB; Rubin RH
Transpl Infect Dis; 2000 Mar; 2(1):2-10. PubMed ID: 11429003
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
[TBL] [Abstract][Full Text] [Related]
12. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
Buhles WC; Mastre BJ; Tinker AJ; Strand V; Koretz SH
Rev Infect Dis; 1988; 10 Suppl 3():S495-506. PubMed ID: 2847286
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cytomegalovirus pneumonia.
Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prophylaxis of cytomegalovirus disease.
Levinson ML; Jacobson PA
Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.
Harbison MA; De Girolami PC; Jenkins RL; Hammer SM
Transplantation; 1988 Jul; 46(1):82-8. PubMed ID: 2839916
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
19. Evaluation of ganciclovir for cytomegalovirus disease.
Fletcher CV; Balfour HH
DICP; 1989 Jan; 23(1):5-12. PubMed ID: 2541566
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
Stein DS; Verano AS; Levandowski RA
Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
